one
hundr
three
patient
nonatop
atop
respiratori
fection
curiou
viral
ugent
studi
retrospect
respect
ige
immunoglobulin
level
acut
day
convalesc
day
phase
infect
found
patient
decreas
ige
level
remain
show
rise
acut
convulesc
phase
infect
ige
level
decreas
wk
symptom
degre
decreas
appar
nonatop
higher
ige
level
acut
phase
infect
less
dramat
decreas
ige
observ
atop
studi
chang
ige
level
viral
infecti
period
discuss
term
possibl
cellular
mechan
may
control
ige
immunoglobulin
clinic
studi
date
back
almost
yr
suggest
upper
respiratori
tract
infect
associ
bronchial
asthma
precipit
potenti
attack
bronchial
asthma
wheez
asthmat
patient
studi
shown
kill
influenza
vaccin
increas
bronchial
sensit
drug
viral
isol
serolog
techniqu
varieti
virus
includ
respiratori
syncyti
viru
parainfluenza
viru
corona
viru
rhinoviru
identifi
patient
asthma
addit
ida
et
found
enhanc
igemedi
histamin
releas
human
basophil
ultravioletinactiv
herp
simplex
influenza
recent
result
frick
et
possibl
viru
infect
associ
found
onset
allerg
sensit
infant
investig
shown
g
decreasedlo
level
ige
associ
viral
infect
purpos
present
studi
examin
close
relationship
viral
infect
ige
level
purpos
retrospect
studi
perform
popul
patient
upper
respiratori
symptom
viral
origin
patient
follow
clinic
screen
viral
bacteri
infect
ige
rast
determin
perform
cours
acut
convalesc
phase
infect
record
region
viru
laboratori
inspect
list
prepar
patient
show
rise
antibodi
level
complementfix
test
one
common
respiratori
agent
first
second
specimen
pair
sera
list
individu
chosen
novemb
march
basi
diagnos
acut
upper
andor
lower
respiratori
infect
onset
fewer
day
submiss
first
blood
specimen
individu
chronic
viral
infect
andor
bacteri
infect
elimin
studi
antigen
test
follow
influenza
solubl
influenza
b
solubl
parainfluenza
type
parainfluenza
type
ii
parainfluenza
type
iii
adenovim
respiratori
syncyti
viru
herp
simplex
viru
psittacosi
group
myoplasma
pneumonia
everi
case
clinic
condit
suffici
sever
warrant
hospit
patient
patient
manifest
bronchiti
tonsil
pharyng
age
rang
mo
yr
half
age
yr
rest
age
yr
clinic
histori
taken
particularli
note
patient
infect
recent
past
atop
state
patient
screen
allergi
use
radioallergosorb
test
piscataway
n
j
sampl
examin
duplic
hand
variat
found
ige
level
rang
use
studi
consid
kittokit
variat
well
variat
kit
kit
standard
standard
provid
prist
kit
also
sever
sera
whose
ige
level
work
rang
pair
acut
convalesc
sera
alway
run
kit
chang
ige
level
consid
signific
phadaba
rast
ige
antibodi
determin
acut
phase
sampl
patient
common
allergen
found
ottawa
area
tree
mapl
birch
oak
elm
grass
sweet
vernal
meadow
fescu
rye
grass
timothi
weed
short
ragwe
western
ragwe
wormwood
mugwort
russian
thistl
mold
arernaria
asprrgillu
cladosporiutn
anim
cat
dog
food
egg
milk
fish
hous
dust
allergen
individu
consid
posit
rast
reaction
found
one
allergen
fig
found
patient
decreas
ige
level
remain
show
rise
immunoglobulin
fig
show
scattergram
summar
ige
level
nonatop
popul
function
time
onset
infect
patient
acut
convalesc
ige
valu
plot
fig
show
similar
scattergram
atop
patient
nonatop
fig
popul
patient
emerg
one
segreg
ige
level
greater
uml
nonatop
valu
nonatop
ii
fig
show
averag
ige
valu
given
time
onset
infect
nonatop
atop
group
respect
decreas
ige
level
observ
high
low
nonatop
group
well
atop
group
patient
seen
fig
decreas
ige
occur
time
onset
symptom
wk
symptom
ige
valu
level
tabl
show
geometr
mean
valu
ige
nonatop
group
ii
well
atop
group
acut
convalesc
phase
infect
seen
ige
level
decreas
group
dramat
nonatop
present
studi
found
natur
occur
viral
respiratori
infect
modul
serum
ige
level
nonatop
well
atop
individu
result
confirm
previou
decreaselo
ige
associ
viral
infect
studi
ige
level
decreas
wk
symptom
hand
ige
level
viral
agent
precipit
asthmat
condit
individu
viral
agent
may
capabl
turn
format
ige
immunoglobulin
suffici
time
prevent
develop
diseas
state
degre
occur
depend
part
cellular
mechan
control
format
ige
immunoglobulin
possibl
viral
infect
helper
cell
stimul
acut
phase
infect
atop
nonatop
produc
ige
immunoglobulin
ige
antibodi
infecti
agent
virus
may
also
activ
suppressor
cell
nonatop
convalesc
phase
decreas
ige
level
atop
increas
evid
genet
determin
defect
lymphocyt
make
vulner
inhibitori
action
cyclic
adenosin
monophosph
camp
substanc
consid
inhibitori
particularli
suppressor
cell
thu
might
expect
convalesc
phase
viral
infect
atop
deupper
respiratori
tract
infect
due
viru
associ
onset
bronchial
asthma
l
tempt
specul
ige
antibodi
infecti
agent
react
respiratori
tract
perelmutt
et
al
feet
suppressor
cell
may
lead
continu
hyperproduct
ige
henc
bronchial
asthma
